Left atrial longitudinal strain by speckle tracking as independent predictor of recurrence after electrical cardioversion in persistent and long standing persistent non-valvular atrial fibrillation

• Published in: The International Journal of Cardiovascular Imaging 2019-09, Vol.35 (9), p.1587-1596
• Main Authors: Moreno-Ruiz, Luis Antonio, Madrid-Miller, Alejandra, Martínez-Flores, Jerónimo Enrique, González-Hermosillo, Jesús Antonio, Arenas-Fonseca, Jorge, Zamorano-Velázquez, Noé, Mendoza-Pérez, Beatriz
• Format: Article
• Language: English
• Subjects: Aged; Arrhythmia; Atrial Fibrillation - diagnostic imaging; Atrial Fibrillation - physiopathology; Atrial Fibrillation - therapy; Atrial Function, Left; Biomechanical Phenomena; Cardiac arrhythmia; Cardiac Imaging; Cardiology; Echocardiography, Doppler, Pulsed - methods; Electric Countershock - adverse effects; Female; Fibrillation; Heart Atria - diagnostic imaging; Heart Atria - physiopathology; Humans; Image Interpretation, Computer-Assisted - methods; Imaging; Male; Medicine; Medicine & Public Health; Middle Aged; Myocardial Contraction; Original Paper; Predictive Value of Tests; Radiology; Recurrence; Reproducibility of Results; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome
• ISSN: 1569-5794; 1875-8312; 1573-0743; 1875-8312
• DOI: 10.1007/s10554-019-01597-7

Atrial fibrillation (AF) is the most common arrhythmia in humans. After successful cardioversion, there is a recurrence of 60% due to atrial remodeling, and it has been shown that the global peak atrial longitudinal strain (GPALS) is decreased in these subjects. The aim of this study was to evaluate the predictive value of GPALS for AF recurrence. A prospective cohort of patients with persistent (PnVAF) and long standing persistent non-valvular AF (LSPnVAF) which underwent electrical cardioversion was evaluated with standard echocardiographic variables and GPALS quantification. The primary endpoint was AF recurrence at 6 months. We included PnVAF (n = 50, aged 68.4 ± 10.2 years, female 46%, lasted AF 6 months) and LSPnVAF (n = 81, aged 66.5 ± 13.1 years, female 36%, lasted AF 18 months). At 6 months there were a 68% of recurrence of AF in PnVAF and 53% in LSPnVAF group. GPALS was lower in recurrence 7.8 ± 2.0% versus 21.2 ± 8.9% (p < 0.001) for PnVAF and 7.3 ± 2.7% versus 20.7 ± 7.6% (p < 0.001) in LSPnVAF. GPALS ≤ 10.75% discriminates recurrence at 6 months with a sensitivity of 85%, specificity 99%, PPV 85%, NPV 90%, LR + 8.5 and LR- 0.17. The independent predictors of recurrence in PnVAF were GPALS ≤ 10.75% HR 8.89 [(2.2–35.7), p < 0.01] meanwhile in LSPnVAF were age HR 1.039 [(1.007-1.071), p = 0.01], and GPALS ≤ 10.75% HR 28.1 [(7.2–109.1), p < 0.001]. In subjects with PnVAF and LSPnVAF with successful electrical cardioversion, GPALS ≤ 10.75% predicts arrhythmia recurrence at 6-month follow-up.